W. Clark
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 4
- Gastroenterology top 5%
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research 3
-
- Health Systems, Economic Evaluations, Quality of Life 2
-
- HIV Research and Treatment 1
-
- Stroke Rehabilitation and Recovery 1
-
- Influenza Virus Research Studies 1
-
- Renal Transplantation Outcomes and Treatments 1
-
- Peripheral Neuropathies and Disorders 1
W. Clark
15 papers receiving 708 citations
Peers
Comparison fields: 5 of 97
- Rheumatology 281
- Gastroenterology 80
- Hematology 116
- Immunology 142
- Genetics 51
Countries citing papers authored by W. Clark
This map shows the geographic impact of W. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Clark more than expected).
Fields of papers citing papers by W. Clark
This network shows the impact of papers produced by W. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Clark. The network helps show where W. Clark may publish in the future.
Co-authorship network
The 22 scholars most cited alongside W. Clark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 5 | |
| 2 | 2007 | 93 | |
| 3 | 2006 | 314 | |
| 4 | 2004 | 75 | |
| 5 | 2003 | 39 | |
| 6 | Technology assessment report commissioned by the HTA Programme on behalf of The National Institute for Clinical Excellence The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults | 2003 | 4 |
| 7 | 2002 | 109 | |
| 8 | West Midlands Health Technology Assessment Collaboration | 2002 | 3 |
| 9 | Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction. | 2001 | 22 |
| 10 | 2001 | 22 | |
| 11 | 1999 | 14 | |
| 12 | 1997 | 9 | |
| 13 | 1996 | 8 | |
| 14 | 1996 | 16 | |
| 15 | 1996 | 8 |
About W. Clark
W. Clark is a scholar working on Medical Laboratory Technology, Pharmacy and Transplantation, having authored 15 papers that have together received 741 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (4 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), HIV Research and Treatment (1 paper), Stroke Rehabilitation and Recovery (1 paper), Influenza Virus Research Studies (1 paper), Renal Transplantation Outcomes and Treatments (1 paper) and Peripheral Neuropathies and Disorders (1 paper). The work is most often cited by research in Rheumatology (281 citations), Gastroenterology (80 citations) and Hematology (116 citations). W. Clark has collaborated with scholars based in United Kingdom, France and Canada. Frequent co-authors include Amanda Burls, Pelham Barton, A Fry-Smith, Paresh Jobanputra, Stirling Bryan, Sue Jowett, Yen‐Fu Chen, David Moore, Peter J. Whorwell and Thomas G. Stewart. Their work appears in journals such as Health Technology Assessment, Canadian Journal of Cardiology, Annals of Pharmacotherapy, Cochrane Database of Systematic Reviews and Journal of Clinical Pharmacy and Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.